Literature DB >> 12744809

Rheumatic manifestations of diabetes mellitus.

Enrico Cagliero1.   

Abstract

An epidemic of diabetes is currently raging in the US and developed countries, and is affecting almost 10% of the US population. The association between several rheumatic disorders and diabetes mellitus is gaining attention, and with recent data showing that more than 30% of patients with type 1 or type 2 diabetes have some hand or shoulder diseases, the magnitude of this problem is becoming more evident. Although some syndromes are observed exclusively in patients with diabetes, the majority of the rheumatic diseases found in patients with diabetes are also seen in the non-diabetes population, albeit at a much lower prevalence. The exact mechanisms by which the specific metabolic abnormalities of diabetes impact on the pathogenesis of its rheumatic manifestations are not clear. Further studies are needed to better understand the role of diabetes on the development of these disorders.

Entities:  

Mesh:

Year:  2003        PMID: 12744809     DOI: 10.1007/s11926-003-0065-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  45 in total

1.  Stiff hands in long-term diabetes.

Authors:  K LUNDBAEK
Journal:  Acta Med Scand       Date:  1957-10-15

2.  Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.

Authors:  E B Jude; P L Selby; J Burgess; P Lilleystone; E B Mawer; S R Page; M Donohoe; A V Foster; M E Edmonds; A J Boulton
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

3.  Diseases associated with calcium pyrophosphate dihydrate crystal deposition.

Authors:  D J McCarty; D C Silcox; F Coe; S Jacobelli; E Reiss; H Genant; M Ellman
Journal:  Am J Med       Date:  1974-05       Impact factor: 4.965

Review 4.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

5.  Changes in frequency and severity of limited joint mobility in children with type 1 diabetes mellitus between 1976-78 and 1998.

Authors:  J R Infante; A L Rosenbloom; J H Silverstein; L Garzarella; B H Pollock
Journal:  J Pediatr       Date:  2001-01       Impact factor: 4.406

6.  Long-term follow-up in diabetic Charcot feet with spontaneous onset.

Authors:  J Fabrin; K Larsen; P E Holstein
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

7.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Scleroderma-like changes in insulin-dependent diabetes mellitus: clinical and biochemical studies.

Authors:  B A Buckingham; J Uitto; C Sandborg; T Keens; T Roe; G Costin; F Kaufman; B Bernstein; B Landing; A Castellano
Journal:  Diabetes Care       Date:  1984 Mar-Apr       Impact factor: 19.112

9.  Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.

Authors:  D R Sell; A Lapolla; P Odetti; J Fogarty; V M Monnier
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

10.  The role of transforming growth factor beta in Dupuytren's disease.

Authors:  M A Badalamente; S P Sampson; L C Hurst; A Dowd; K Miyasaka
Journal:  J Hand Surg Am       Date:  1996-03       Impact factor: 2.230

View more
  3 in total

1.  Prevalence of musculoskeletal disorders in patients with type 2 diabetes mellitus: a pilot study.

Authors:  I Douloumpakas; A Pyrpasopoulou; A Triantafyllou; Ch Sampanis; S Aslanidis
Journal:  Hippokratia       Date:  2007-10       Impact factor: 0.471

2.  Cytogenetic analysis of the pathology of frozen shoulder.

Authors:  Benjamin Kabbabe; Satish Ramkumar; Martin Richardson
Journal:  Int J Shoulder Surg       Date:  2010-07

3.  Musculoskeletal manifestations in diabetic patients at a tertiary center.

Authors:  Suzan M Attar
Journal:  Libyan J Med       Date:  2012-10-29       Impact factor: 1.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.